dl-Amphetamine
Brand names,
dl-Amphetamine
Analogs
dl-Amphetamine
Brand Names Mixture
- Adderall (amphetamine + dextroamphetamine)
- Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
dl-Amphetamine
Chemical_Formula
C9H13N
dl-Amphetamine
RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
dl-Amphetamine
fda sheet
dl-Amphetamine
msds (material safety sheet)
dl-Amphetamine
Synthesis Reference
U. S. Pat. 1,879,003, (1932)
dl-Amphetamine
Molecular Weight
135.206 g/mol
dl-Amphetamine
Melting Point
Volatizes slowly at room temperature
dl-Amphetamine
H2O Solubility
Slightly
dl-Amphetamine
State
Solid
dl-Amphetamine
LogP
1.799
dl-Amphetamine
Dosage Forms
Capsules
dl-Amphetamine
Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
dl-Amphetamine
Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
dl-Amphetamine
Absorption
It forms easily absorbed molecules that are highly lipid soluble
dl-Amphetamine
side effects and Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
dl-Amphetamine
Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
dl-Amphetamine
Organisms Affected
Humans and other mammals